NEPH - Nephros Inc Stock Price, Fair Value and News

$1.42+0.02 (+1.43%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

NEPH Price Action

Last 7 days

-6.1%

Last 30 days

-22.9%

Last 90 days

-37.0%

Trailing 12 Months

-13.8%

NEPH RSI Chart

NEPH Valuation

Market Cap

14.8M

Price/Earnings (Trailing)

-11.41

Price/Sales (Trailing)

1.05

EV/EBITDA

-4.45

Price/Free Cashflow

-23.64

NEPH Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

NEPH Fundamentals

NEPH Revenue

Revenue (TTM)

14.0M

Rev. Growth (Yr)

-8.27%

Rev. Growth (Qtr)

-7.67%

NEPH Earnings

Earnings (TTM)

-1.3M

Earnings Growth (Yr)

33.26%

Earnings Growth (Qtr)

-71.01%

NEPH Profitability

EBT Margin

-32.29%

Return on Equity

-16.33%

Return on Assets

-11.66%

Free Cashflow Yield

-4.23%

NEPH Investor Care

Shares Dilution (1Y)

0.56%

Diluted EPS (TTM)

-0.13

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	13.3M	14.0M	0	0
2023	11.5M	12.2M	0	0
2022	9.7M	10.3M	10.2M	10.0M
2021	8.8M	9.5M	9.9M	10.3M
2020	0	0	0	8.6M
2018	0	0	0	0
2017	2.5M	2.8M	3.3M	0
2016	2.0M	1.9M	2.1M	2.3M
2015	1.8M	1.9M	1.8M	1.9M
2014	1.7M	1.6M	1.6M	1.7M
2013	1.8M	2.1M	1.9M	1.7M
2012	2.1M	1.7M	1.9M	1.8M
2011	2.6M	2.5M	2.2M	2.2M
2010	0	2.8M	2.8M	2.9M
2009	0	0	0	2.7M

Get all data in R, Python etc through our Historical Stock Data APIs

About Nephros Inc

Nephros, Inc. engages in development and sale of high performance water solutions to the medical and commercial markets in the United States. The company operates in two segments: Water Filtration and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also develops and sells medical device products for patients with renal disease, including a second generation hemodiafiltration system for the treatment of patients with end stage renal disease. In addition, it manufactures and sells water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and Nanoguard brands for the food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

CEO	Mr. Robert Banks
WEBSITE	nephros.com
SECTOR	Healthcare
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	27

Nephros Inc Frequently Asked Questions

What is the ticker symbol for Nephros Inc? What does NEPH stand for in stocks?

NEPH is the stock ticker symbol of Nephros Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Nephros Inc (NEPH)?

As of Mon Oct 28 2024, market cap of Nephros Inc is 14.76 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NEPH stock?

You can check NEPH's fair value in chart for subscribers.

Is Nephros Inc a good stock to buy?

The fair value guage provides a quick view whether NEPH is over valued or under valued. Whether Nephros Inc is cheap or expensive depends on the assumptions which impact Nephros Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NEPH.

What is Nephros Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Mon Oct 28 2024, NEPH's PE ratio (Price to Earnings) is -11.41 and Price to Sales (PS) ratio is 1.05. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NEPH PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Nephros Inc's stock?

In the past 10 years, Nephros Inc has provided -0.157 (multiply by 100 for percentage) rate of return.